24147/34351US=84-A / Biol/Mol
Piestrzeniewicz-Ulanska D, McGuinness DH, Yeaman GR. Transformig growth factor-B in developing and advanced cancers: TGF-B signaling in endometrial cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 63-78. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

CANCER ENDOMETRIAL; ENDOMETRIO; SMADS; HORMONIOS ESTEROIDES; TGF-B; TGF-B RECEPTORES

24148/34351US=84-A / Biol/Mol
Wang GY, Hu XH, Zhang RM, Leach L, Luo ZW. Transformig growth factor-B in developing and advanced cancers: TGF-B ligands, TGF-B receptors, and lung cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 79-93. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

DNA METILACAO; CANCER DE PULMAO; TERAPIA DO CANCER; SMAD PROTEINAS; MUTACAO GENETICA; MIGRACAO DO TUMOR; TGF-B LIGANDOS; TGF-B RECEPTORES

24149/34351US=84-A / Biol/Mol
Bartholin L, Guise T. Transformig growth factor-B in developing and advanced cancers: role of TGF-B in osteolytic bone metastases. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 95-123. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TGF-B; MAMA; OSSO; METATASE; SMAD; TERAPIA

24150/34351US=84-A / Biol/Mol
Buck M, Knabbe. Transformig growth factor-B in developing and advanced cancers: hormonal regulation of transforming growth factor-B in breast cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 125-32. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

ANTIESTROGENIO; CANCER DE MAMA; ESTROGENIO; REGULACAO HORMONAL; PROGESTINA; RETINOIDE; RESISTENCIA; TGF-B

24151/34351US=84-A / Biol/Mol
Fukuchi M, Kato H, Kuwano H. Transformig growth factor-B in developing and advanced cancers: TGF-B and progression of esophageal cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 133-40. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TGF-B; SMAD; PROGNOSTICO; CANCER DE ESOFAGO; DEGRADACAO

24152/34351US=84-A / Biol/Mol
Todorovic-Rakovic N. Transformig growth factor-B in developing and advanced cancers: TGF-B and HER2/ErbB2 and beast cancer progression. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 141-51. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TGF-B; HER2; CANCER DE MAMA; SMAD; RAS/MAPK; SINERGISMO; PROGRESSAO

24153/34351US=84-A / Biol/Mol
Becker C, Neurath MF. Transformig growth factor-B in developing and advanced cancers: TGF-B dependent T-Cell regulation in colitis and colon cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 153-66. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TGF-B; CD25; COLITE; CANCRO DO COLON; TREG; FOXP3; CELULA T; REGULACAO

24154/34351US=84-A / Biol/Mol
Gagliardini E, Benigni A. Transformig growth factor-B in developing and advanced cancers: role of transforming growth factor-B in the kidney-physiology and pathology. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 167-79. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

FATOR TRANSFORMADOR DE CRESCIMENTO - B; PODOCITOS; FIBROSE RENAL; NEFROPATIA PROGRESSIVA; PROTEINURIA; GLOMERULOESCLEROSE

24155/34351US=84-A / Biol/Mol
Wolfrain LA, Letterio JJ. Transformig growth factor-B in developing and advanced cancers: perturbations of TGF-B signaling in leukocytes as drivers of leukemogenesis and epithelial tumorigenesis. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 181-202. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

FATOR TRANSFORMADOR DE CRESCIMENTO - B; TGF-B; SMAD; LEUCEMOGENESE; CELULAS T; IMUNOTERAPIA TUMOR; MODELOS DE RATO; ESTROMA; LINFOCITOS EPITELIAIS INTERACCOES

24156/34351US=84-A / Biol/Mol
Vivien D, Benchenane K, Ali C. Transformig growth factor-B in developing and advanced cancers: transforming growth factor-B in brain functions and dysfunctions. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 203-18. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TGF-B; DOENCA DE ALZHEIMER'S; INFLAMACAO; CEREBRO; GOLPE

24157/34351US=84-A / Biol/Mol
Yasui H, Hideshima T, Anderson KC. Transformig growth factor-B in developing and advanced cancers: inhibition of TGF-B signaling in multiple myeloma and its bone marrow microenvironment. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 219-27. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TGF-B; IL-6; VEGF; TGF-B RECEPTOR TIPO I; TBRI; MIELOMA MULTIPLO; MICROAMBIENTE DA MEDULA OSSEA; FATOR TRANSFORMADOR DE CRESCIMENTO; FACTOR DE CRESCIMENTO ENDOTELIAL VASCULAR; INIBIDOR DE QUINASE SD-208

24158/34351US=84-A / Biol/Mol
Song K, Danielpour D. Transformig growth factor-B in developing and advanced cancers: key roles of TGF-B and smad3 in prostate cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 229-46. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

PROSTATA; SMAD3; IGF-I; AKT; MTOR; ARA55/HIC-5; RECEPTOR DE ANDROGENO

24159/34351US=84-A / Biol/Mol
Ruscetti F, Akel S, Birchenall-Roberts M, Cao Z, Roberts AB. Transformig growth factor-B in developing and advanced cancers: smad signaling in leukemic growth and differentiation: crosstalk between smad and multiple pathways through activation of the TGF-B type I receptor. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 247-61. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

FATOR TRANSFORMADOR DE CRESCIMENTO - B; LEUCEMIA; DIFERENCIACAO; CROSSTALK SMAD SINALIZACAO; MAPK SINALIZACAO TUBERINA

24160/34351US=84-A / Biol/Mol
Barrios-Rodiles M, Viloria-Petit A, Brown KR, Jurisica I, Wrana JL. Transformig growth factor-B in developing and advanced cancers: high-throughput screening of protein interaction networks in the TGFB interactome: understanding the signaling mechanisms driving tumor progression. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 265-84. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

RENDIMENTO ELEVADO; INTERACOES PROTEINA-PROTEINA; REDES; EMT; METASTASE

24161/34351US=84-A / Biol/Mol
Wilkinson DS, Barton MC. Transformig growth factor-B in developing and advanced cancers: tumor suppressors p53 and TGFB converge to regulate the alpha-fetoprotein oncodevelopmental tumor marker. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 309-20. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

P53; SMAD2; SMAD4; SNON; P73; CROMATINA; FIGADO; HEPATOMA

24162/34351US=84-A / Biol/Mol
Wilkinson DS, Barton MC. Transformig growth factor-B in developing and advanced cancers: tumor suppressors p53 and TGFB converge to regulate the alpha-fetoprotein oncodevelopmental tumor marker. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 309-20. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

P53; SMAD2; SMAD4; SNON; P73; CROMATINA; HEPATOMA

24163/34351US=84-A / Biol/Mol
Andarawewa KL, Kirshner J, Mott JD, Barcellos-Hoff MH. Transformig growth factor-B in developing and advanced cancers: TGFB: roles in DNA damage responses. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 321-33. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TGFB; DNA DANO; RADIACAO IONIZANTE

24164/34351US=84-A / Biol/Mol
Hjelmeland AB, Rich JN. Transformig growth factor-B in developing and advanced cancers: the rationale for and effects of tergeting TGF-B for glioma therapy. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 335-51. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

GLIOBLASTOMA; FORKHEAD; P15; P21; PAI-1; PETN; VEGF; SB-431542; SD-208

24165/34351US=84-A / Biol/Mol
Bommireddy R, Doetschman T. Transformig growth factor-B in developing and advanced cancers: tumor suppressor functions of TGFB1 in T cells. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 353-66. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

FOXP3; SMAD; TGF-B1; TREG CELULAS; TUMORES; CALCIO; AUTOIMUNIDADE; CAMUNDONGOS KNOCKOUT; CELULAS T

24166/34351US=84-A / Biol/Mol
Saika S. Transformig growth factor-B in developing and advanced cancers: therapeutic effects of adenovirus medated gene transfer of TGF-B signal antagonists on undesirable epithelial-mesenchymal transition and neovascularization. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 367-81. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TRANSICAO EPITELIAL-MESENQUIMAL; NEOVASCULARIZACAO; CICATRIZACAO DE FERIDAS; FACTOR DE CRESCIMENTO TRANSFORMANTE B; TRANSDUCAO DE SINAL; TERAPIA GENETICA

Primeira | Anterior | Próxima | Última